Crescent Biopharma Inc. (CBIO)
NASDAQ: CBIO
· Real-Time Price · USD
11.72
-0.31 (-2.58%)
At close: Oct 03, 2025, 3:59 PM
11.72
0.00%
After-hours: Oct 03, 2025, 05:45 PM EDT
Crescent Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 10K | n/a | n/a | n/a | n/a | n/a | 75K | n/a | 17.63K | 86.56K | 142.00 | 1.06M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | 10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -21.03M | -2.4M | -7.33M | -11.23M | -10.36M | -11.12M | -9.59M | -9.81M | -8.93M | -10.94M | -10.62M | -8.77M | -13.35M | -14.66M | -17.43M | -17.34M | -14.4M | -14.28M |
Interest Income | 313K | 55.14K | 110.11K | 184.52K | 262.29K | 378.36K | 512.19K | 610.98K | 671.03K | 581.67K | 378.26K | 243.6K | 85.59K | 7.07K | 4.08K | 4.63K | 5.22K | 5.85K |
Pretax Income | -21.79M | -2.34M | -7.22M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M | -14.27M |
Net Income | -21.79M | -2.34M | -7.22M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M | -14.27M |
Selling & General & Admin | 8.95M | 2.38M | 5.08M | 4.01M | 4.07M | 5.09M | 4.31M | 4.52M | 4.86M | 5.52M | 4.73M | 3.85M | 5.46M | 5.06M | 4.55M | 4.14M | 4.24M | 4.19M |
Research & Development | 12.08M | 14.78K | 233.21K | 1.72M | 6.29M | 6.03M | 5.29M | 5.29M | 4.07M | 5.42M | 5.89M | 4.92M | 7.97M | 9.6M | 12.9M | 13.28M | 10.17M | 11.15M |
Other Expenses | n/a | n/a | 2.02M | 5.51M | -40 | n/a | 382.00 | -294 | 237.00 | 312.00 | 799.00 | -421 | -123 | 188.00 | -404 | -48 | 342.00 | 110.00 |
Operating Expenses | 21.03M | 2.4M | 7.33M | 11.23M | 10.36M | 11.12M | 9.6M | 9.81M | 8.93M | 10.94M | 10.62M | 8.77M | 13.43M | 14.66M | 17.44M | 17.42M | 14.4M | 15.34M |
Interest Expense | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.03M | 2.4M | 7.33M | 11.23M | 10.36M | 11.12M | 9.6M | 9.81M | 8.93M | 10.94M | 10.62M | 8.77M | 13.43M | 14.66M | 17.44M | 17.42M | 14.4M | 15.34M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
Shares Outstanding (Diluted) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
EPS (Basic) | -4.93 | -0.04 | -0.11 | -0.15 | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 | -0.16 | -0.55 | -0.16 | -0.25 | -0.28 | -0.33 | -0.34 | -0.28 | -0.28 |
EPS (Diluted) | -4.93 | -0.04 | -0.11 | -0.15 | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 | -0.16 | -0.55 | -0.16 | -0.25 | -0.28 | -0.33 | -0.34 | -0.28 | -0.28 |
EBITDA | -20.72M | -2.4M | -5.31M | -5.71M | -10.35M | -11.1M | -9.57M | -9.77M | -8.89M | -10.9M | -10.58M | -8.72M | -13.3M | -14.6M | -17.36M | -17.27M | -14.34M | -14.21M |
EBIT | -20.72M | -2.4M | -5.31M | -5.72M | -10.36M | -11.12M | -9.59M | -9.81M | -8.93M | -10.94M | -10.62M | -8.77M | -13.35M | -14.66M | -17.43M | -17.34M | -14.4M | -14.28M |
Depreciation & Amortization | n/a | n/a | n/a | 8.13K | 12.42K | 14.62K | 23.3K | 42.75K | 43.42K | 43.84K | 45.72K | 47.35K | 54.77K | 59.31K | 61.64K | 67.38K | 67.48K | 68.09K |